Download interactions: TXT MITAB-2.5
Interaction | Interactor | Experiments | Homologs | Category | Interaction Score |
Confidence |
---|---|---|---|---|---|---|
MCU
Calcium uniporter protein, mitochondrial |
3 |
0 |
Small-scale |
0.809 | High |
|
EID3
EP300-interacting inhibitor of differentiation 3 |
3 |
0 |
High-throughput |
0.638 | High |
|
HDHD5
Haloacid dehalogenase-like hydrolase domain-containing 5 |
1 |
0 |
High-throughput |
0.513 | High |
|
S22A4
Solute carrier family 22 member 4 |
1 |
0 |
High-throughput |
0.513 | High |
|
PARP4
Protein mono-ADP-ribosyltransferase PARP4 |
1 |
0 |
High-throughput |
0.513 | High |
|
MTOR
Serine/threonine-protein kinase mTOR |
1 |
0 |
High-throughput |
0.458 | High |
|
EI2BB
Translation initiation factor eIF2B subunit beta |
1 |
2 |
High-throughput |
0.437 | High |
|
EI2BE
Translation initiation factor eIF2B subunit epsilon |
1 |
2 |
High-throughput |
0.437 | High |
|
EI2BA
Translation initiation factor eIF2B subunit alpha |
1 |
2 |
High-throughput |
0.437 | High |
|
EI2BG
Translation initiation factor eIF2B subunit gamma |
1 |
1 |
High-throughput |
0.437 | High |
|
EI2BD
Translation initiation factor eIF2B subunit delta |
1 |
2 |
High-throughput |
0.437 | High |
|
5MP1
eIF5-mimic protein 1 |
1 |
1 |
High-throughput |
0.437 | High |
|
MYLK2
Myosin light chain kinase 2, skeletal/cardiac muscle |
3 |
0 |
High-throughput |
0.342 | High |
|
ASPH
Aspartyl/asparaginyl beta-hydroxylase |
2 |
0 |
High-throughput |
0.328 | High |
|
GP183
G-protein coupled receptor 183 |
2 |
0 |
High-throughput |
0.318 | High |
|
IL2RA
Interleukin-2 receptor subunit alpha |
1 |
0 |
High-throughput |
0.279 | Low |
|
CO1A1
Collagen alpha-1(I) chain |
1 |
0 |
High-throughput |
0.279 | Low |
|
AT12A
Potassium-transporting ATPase alpha chain 2 |
1 |
0 |
High-throughput |
0.279 | Low |
|
PDCD1
Programmed cell death protein 1 |
1 |
0 |
High-throughput |
0.279 | Low |
|
TEP1
Telomerase protein component 1 |
1 |
0 |
High-throughput |
0.279 | Low |
Service provided by Combinatics, Japan
Last updated: 15 Jul 2024